Tag: annual

  • VW CEO eyes solid 2016 growth despite crisis

    Volkswagen has a chance of posting solid growth in its operating business this year even as it grapples with its diesel emissions scandal and a strategic repositioning, Chief Executive Matthias Mueller said. Cost reductions at Europe's largest automaker are “in full swing” at individual brands and across the group, Mueller said at Volkswagen's (VW) earnings…

  • Kids who skip lunch are missing out on essential nutrients

    By Shereen Lehman (Reuters Health) – Children who skip lunch may not be getting enough vitamins and minerals from the rest of their meals and snacks, a study suggests. “Overall, the lunch meal is very important for helping children meet their nutrient needs, especially for fat-soluble vitamins A and D, minerals like calcium, phosphorus and…

  • Valeant to appoint interim CEO as Pearson remains hospitalized: source

    By Sneha Banerjee and Carl O'Donnell (Reuters) – Valeant Pharmaceuticals International Inc will appoint an interim chief executive officer to replace Michael Pearson who is hospitalized, a source familiar with the matter told Reuters, news that sent shares down 7 percent on Tuesday. The source did not clarify whether the CEO would be temporary or…

  • Valeant to appoint interim CEO as Pearson remains hospitalized: source

    By Sneha Banerjee and Carl O'Donnell (Reuters) – Valeant Pharmaceuticals International Inc will appoint an interim chief executive officer to replace Michael Pearson who is hospitalized, a source familiar with the matter told Reuters, news that sent shares down 7 percent on Tuesday. The source did not clarify whether the CEO would be temporary or…

  • Snyder declares emergency in Flint over water problems

    DETROIT (AP) — Michigan Gov. Rick Snyder declared a state of emergency in Flint on Tuesday over problems with lead in the city’s drinking water, the same day federal officials confirmed they’re investigating the matter that prompted a local public health emergency.

  • Conatus liver drug shows promise in mid-stage trial

    (Reuters) – Conatus Pharmaceuticals Inc said its experimental drug reduced the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial. The drug, emricasan, showed a statistically significant reduction in the protein fragment, caspase-cleaved cytokeratin 18 (cCK18), when compared with a placebo, in the overall patient population, according to the three-month…

  • Valeant CEO Pearson remains hospitalized for pneumonia: Bloomberg

    Valeant Pharmaceuticals International Inc Chief Executive J. Michael Pearson has been moved to another hospital where he is being treated for a severe case of pneumonia, a company spokeswoman told Bloomberg on Sunday. Elaine Andrecovich, a public relations manager at Morristown Medical Center, where Pearson initially was admitted for treatment on Friday, confirmed that Pearson…

  • Valeant CEO Pearson remains hospitalized for pneumonia: Bloomberg

    Valeant Pharmaceuticals International Inc Chief Executive J. Michael Pearson has been moved to another hospital where he is being treated for a severe case of pneumonia, a company spokeswoman told Bloomberg on Sunday. Elaine Andrecovich, a public relations manager at Morristown Medical Center, where Pearson initially was admitted for treatment on Friday, confirmed that Pearson…

  • Taiwan economy: an aging tiger in need of cubs

    By Faith Hung TAIPEI (Reuters) – Jason Tsai is among the few in Taiwan with excellent English, but two years after graduating from university the highly sought language skill has failed to secure him a well-paying job. Tsai has been pulling in an average monthly pay of T$15,000 ($455) through part-time work, below the minimum…

  • Valeant says CEO J. Michael Pearson hospitalized with severe pneumonia

    Valeant Pharmaceuticals International Inc Chief Executive J. Michael Pearson was hospitalized with a “severe case of pneumonia” on Friday and is receiving treatment, a company spokeswoman said. Pearson, 56, joined Valeant as CEO in September 2010 after a 23-year career at McKinsey & Company and became chairman of the board in 2010. Under Pearson's leadership,…